The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 130:603-605, May 1973
doi: 10.1176/appi.ajp.130.5.603
© 1973 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by JOHNSON, A. C.
* Articles by KULKARNI, A. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by JOHNSON, A. C.
* Articles by KULKARNI, A. S.

Piperacetazine and Chlorpromazine: A Comparison

ALONZA C. JOHNSON M.D.1, and A. S. KULKARNI M.D., PH.D.2

1 Consultant Psychiatrist, Contra Costa County Hospital, Martinez, Calif. 94553
2 Clinical Monitor and Research Pharmacologist, Human Health Medical Department, Dow Pharmaceuticals Research Center, Zionsville, Ind. 46077

Twenty-six agitated acute schizophrenic patients in a state hospital received intramuscular injections of either piperacetazine or chlorpromazine. Three rating scales were used to assess the effects of the drugs. Both drugs were found to be effective in producing significant improvement in the patients. Piperacetazine appeared to be more potent than chlorpromazine. No side effects were observed.







Get information about faster international access.

Privacy Policy

Copyright © 1973 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org